Increasing the dose of ASA from 75 mg to 150 mg daily or switching ASA 75 mg to clopidogrel 75 mg daily may reduce concentrations of some inflammatory markers ( in particular hsCRP , IL-6 and CD40L ) in T2DM patients with HPR treated previously with 75 mg of ASA .